SCIENTIFIC HUB

MCT Academy

Clinical research, published studies and expert webinars behind Meta Cell Technology’s biomodulation platform. Designed for physicians, surgeons and aesthetic practitioners committed to evidence-based regenerative medicine.

Latest webinars

Live and recorded sessions from leading clinicians.

Breaking the Pain Cycle: A Clinical Perspective on PRP-Derived Exosomes
Webinar banner: Breaking the Pain Cycle, a clinical perspective on PRP-derived exosomes, with Dr. Hany Demian
Breaking the Pain Cycle: A Clinical Perspective on PRP-Derived ExosomesOrthopedics

Breaking the Pain Cycle: A Clinical Perspective on PRP-Derived Exosomes

Hany Demian, MD, MBBCH, CCFP (29 October 2026, 60 min)
De la ciencia a la práctica clínica: MCT System y Exo-Tech
De la ciencia a la práctica clínica: MCT System y Exo-TechRegenerative Medicine

De la ciencia a la práctica clínica: MCT System y Exo-Tech

In Spanish. Adrià Reigosa, MSc — R&D, Meta Cell Technology; Laura Cordero, PhD, MSc —…
Beyond Resurfacing: Autologous Exosomes in Combined Acne Scar Treatment
Beyond Resurfacing: Autologous Exosomes in Combined Acne Scar TreatmentDermatology

Beyond Resurfacing: Autologous Exosomes in Combined Acne Scar Treatment

Madiha Azmat Rao, MD, MSc (17 July 2026, 46 min)

Latest publications

Peer-reviewed research on MCT technology.

Sequential Management of Stage 3/Type III Lipedema With a Ketogenic Dietary Phase Followed by Adjunctive Photothermal Biomodulated Autologous Platelet-Rich Plasma: A Descriptive Case Report
First page of the paper: Sequential Management of Stage 3/Type III Lipedema With a Ketogenic Dietary Phase Followed by Adjunctive Photothermal Biomodulated Autologous Platelet-Rich Plasma: A Descriptive Case Report
Sequential Management of Stage 3/Type III Lipedema With a Ketogenic Dietary Phase Followed by Adjunctive Photothermal Biomodulated Autologous Platelet-Rich Plasma: A Descriptive Case ReportMCT PublicationsRegenerative Medicine

Sequential Management of Stage 3/Type III Lipedema With a Ketogenic Dietary Phase Followed by Adjunctive Photothermal Biomodulated Autologous Platelet-Rich Plasma: A Descriptive Case Report

American Journal of Case Reports, 2026 — Isabel Bové Farré, Margherita Falcomer et al.
Photothermal-Activated Platelet-Rich Plasma Versus Conventional Platelet-Rich Plasma for Melasma: A Split-Face, Double-Blind Randomized Controlled Trial
First page of the paper: Photothermal-Activated Platelet-Rich Plasma Versus Conventional Platelet-Rich Plasma for Melasma: A Split-Face, Double-Blind Randomized Controlled Trial
Photothermal-Activated Platelet-Rich Plasma Versus Conventional Platelet-Rich Plasma for Melasma: A Split-Face, Double-Blind Randomized Controlled TrialDermatologyMCT Publications

Photothermal-Activated Platelet-Rich Plasma Versus Conventional Platelet-Rich Plasma for Melasma: A Split-Face, Double-Blind Randomized Controlled Trial

Photodermatology, Photoimmunology & Photomedicine, 2026 — Rueangrit Siriphanit, Nattachar Ranoppawan, Sasin Charoensuksira et al.
Molecular mechanisms of the geroprotective effect of exosomes in the simulation of inflammaging in the culture of human fibroblasts
First page of the paper: Molecular mechanisms of the geroprotective effect of exosomes in the simulation of inflammaging in the culture of human fibroblasts
Molecular mechanisms of the geroprotective effect of exosomes in the simulation of inflammaging in the culture of human fibroblastsMCT PublicationsRegenerative Medicine

Molecular mechanisms of the geroprotective effect of exosomes in the simulation of inflammaging in the culture of human fibroblasts

Advances in Gerontology, 2026 — Yu.I. Belova, A.I. Fedorina, A.O. Drobintseva et al.

FACULTY

The MCT Academy Faculty

Clinicians and scientists appointed to lead medical education on MCT technology.

Meet the Faculty

Support

Need support from our Medical Team?

Our clinical and scientific team is available to support practitioners using MCT technology.

Let’s talk